The report will be delivered in 2-3 business days.

Therapeutic Proteins Global Market Report 2021: COVID 19 Impact and Recovery to 2030

Starting Price : $5000 | Pages : 175 | Published : January 2021 | SKU CODE : 7183 | Format :


The therapeutic proteins market consists of sales of therapeutic proteins. Therapeutic proteins provide important therapies for diseases such as diabetes, cancer, infectious diseases, hemophilia, and anemia.

The global therapeutic proteins market is expected to grow from $90.53 billion in 2020 to $98.1 billion in 2021 at a compound annual growth rate (CAGR) of 8.4%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $155.06 billion in 2025 at a CAGR of 12.1%.

Advance technologies for protein-based drug development drives the therapeutic proteins market. Therapeutic proteins cannot be synthesized chemically, they need to be produced by genetic engineering and recombinant DNA technology in living cells or organisms. Protein-engineering platform technologies such as glycoengineering, pegylation, Fc-fusion, albumin fusion, albumin drug conjugation help to increase the production yield, product purity, circulating half-life, targeting, and functionality of therapeutic protein drugs. Belimumab, ipilimumab, taliglucerase alfa, albiglutide, coagulation factor IX recombinant human are some therapeutic protein drugs developed using protein engineering technologies approved by FDA in the past five years.

Increasing biosimilar drugs in global market decline the growth of the therapeutic proteins market. Patent expiry of therapeutic proteins such as monoclonal antibodies give space for entry of biosimilar. In EU, AbbVie evidenced patent expiration of Humira (adalimumab) in 2018, five biosimilar of Humira from Mylan, Amgen, Sandoz, Samsung Bioepis received drug approvals from European commission to enter the EU market. These cost-effective treatments similar to original biologics decline the revenue and sales of therapeutic proteins.

Monoclonal antibody drug approvals are increasing in the protein therapeutic segment. Chronic diseases such as cancer, immunological disorders are well treated with monoclonal antibodies. Monoclonal antibodies are dominant and well-established product class in the protein therapeutic segment with more safety and immunogenicity than antibodies. Cell-based expression systems such as Chinese hamster ovary (CHO) mammalian cell expression system with latest technologies increased the productivity of monoclonal antibodies by overcoming the problems associated with earlier antibody drugs. In last five years, FDA approved 213 drugs, among them 44 are monoclonal antibodies. In 2018, twelve monoclonal antibodies were approved by FDA for the treatment of cancer and immunological disorders.

In the United States, therapeutic protein drug manufacturers file therapeutic biologics application (BLA) to FDA for the product approvals. The drug approved through BLA should be proved as safe, pure and potent. FDA consolidated review of most therapeutic proteins in Center for Drug Evaluation and Research (CDER). In European Union, biologics are regulated by Committee for Medicinal Products for Human Use (CHMP) for marketing authorization.

In June 2018, Sanofi, a therapeutic solutions provider acquired Ablynx for $4.8 billion. With this acquisition, Sanofi strengthen its R&D strategy with the addition of Ablynx’s nanobody technology platform. Sanofi will also focus on technologies addressing multiple disease targets with single multi-specific molecules. Ablynx, a biopharmaceutical company based in Ghent, Belgium, that develops proprietary therapeutic proteins based on single-domain antibody fragments.

Major players in the market are Abbott Laboratories, Amgen Inc., Baxter International Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd.

The countries covered in the global therapeutic proteins market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia.

The regions covered in the global therapeutic proteins market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The global therapeutic proteins market is segmented -

1) By Product Type: Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone

2) By Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Others

3) By Function: Enzymatic and Regulatory Activity, Special Targeting Activity, Vaccines, Protein Diagnostics

    1. Executive Summary

    2. Therapeutic Proteins Market Characteristics

    3. Therapeutic Proteins Market Trends And Strategies

    4. Impact Of COVID-19 On Therapeutic Proteins

    5. Therapeutic Proteins Market Size And Growth

    5.1. Global Therapeutic Proteins Historic Market, 2015-2020, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Therapeutic Proteins Forecast Market, 2020-2025F, 2030F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Therapeutic Proteins Market Segmentation

    6.1. Global Therapeutic Proteins Market, Segmentation  By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Insulin

    Fusion Protein

    Erythropoietin

    Interferon

    Human Growth Hormone

    Follicle Stimulating Hormone

    6.2. Global Therapeutic Proteins Market, Segmentation  By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Metabolic Disorders

    Immunologic Disorders

    Hematological Disorders

    Cancer

    Hormonal Disorders

    Genetic Disorders

    Others

    6.3. Global Therapeutic Proteins Market, Segmentation  By Function, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Enzymatic and Regulatory Activity

    Special Targeting Activity

    Vaccines

    Protein Diagnostics

    7. Therapeutic Proteins Market Regional And Country Analysis

    7.1. Global Therapeutic Proteins Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    7.2. Global Therapeutic Proteins Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8. Asia-Pacific Therapeutic Proteins Market  

    8.1. Asia-Pacific Therapeutic Proteins Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8.3. Asia-Pacific Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    9. China Therapeutic Proteins Market  

    9.1. China Therapeutic Proteins Market Overview  

    9.2. China Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    9.3. China Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    10. India Therapeutic Proteins Market  

    10.1. India Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    10.2. India Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11. Japan Therapeutic Proteins Market  

    11.1. Japan Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11.2. Japan Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12. Australia Therapeutic Proteins Market  

    12.1. Australia Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12.2. Australia Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13. Indonesia Therapeutic Proteins Market  

    13.1. Indonesia Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13.2. Indonesia Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14. South Korea Therapeutic Proteins Market  

    14.1. South Korea Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14.2. South Korea Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15. Western Europe Therapeutic Proteins Market  

    15.1. Western Europe Therapeutic Proteins Market Overview

    15.2. Western Europe Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15.3. Western Europe Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16. UK Therapeutic Proteins Market  

    16.1. UK Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16.2. UK Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17. Germany Therapeutic Proteins Market  

    17.1. Germany Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17.2. Germany Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18. France Therapeutic Proteins Market  

    18.4. France Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18.5. France Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19. Eastern Europe Therapeutic Proteins Market  

    19.1. Eastern Europe Therapeutic Proteins Market Overview

    19.2. Eastern Europe Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19.3. Eastern Europe Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20. Russia Therapeutic Proteins Market  

    20.1. Russia Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20.2. Russia Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21. North America Therapeutic Proteins Market  

    21.1. North America Therapeutic Proteins Market Overview

    21.2. North America Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21.3. North America Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22. USA Therapeutic Proteins Market  

    22.1. USA Therapeutic Proteins Market Overview

    22.2. USA Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22.3. USA Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23. South America Therapeutic Proteins Market  

    23.1. South America Therapeutic Proteins Market Overview

    23.2. South America Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23.3. South America Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24. Brazil Therapeutic Proteins Market  

    24.1. Brazil Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24.2. Brazil Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25. Middle East Therapeutic Proteins Market  

    25.1. Middle East Therapeutic Proteins Market Overview

    25.2. Middle East Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25.3. Middle East Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26. Africa Therapeutic Proteins Market  

    26.1. Africa Therapeutic Proteins Market Overview

    26.2. Africa Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26.3. Africa Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    27. Therapeutic Proteins Market Competitive Landscape And Company Profiles

    27.1. Therapeutic Proteins Market Competitive Landscape

    27.2. Therapeutic Proteins Market Company Profiles

    27.2.1. Abbott Laboratories

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Amgen Inc

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Baxter International Inc

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Eli Lilly and Company

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. F. Hoffmann-La Roche Ltd

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Therapeutic Proteins Pipeline Analysis

    29. Key Mergers And Acquisitions In The Therapeutic Proteins Market

    30. Therapeutic Proteins Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Research Inquiries

    31.4. The Business Research Company

    31.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Table 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Table 3: Global Therapeutic Proteins Market, Segmentation  By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 4: Global Therapeutic Proteins Market, Segmentation  By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 5: Global Therapeutic Proteins Market, Segmentation  By Function, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 6: Global Therapeutic Proteins Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global Therapeutic Proteins Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: China, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: China, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 12: India, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 13: India, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 14: Japan, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 15: Japan, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 16: Australia, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 17: Australia, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 18: Indonesia, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 19: Indonesia, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 20: South Korea, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 21: South Korea, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 22: Western Europe, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 23: Western Europe, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 24: UK, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 25: UK, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 26: Germany, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 27: Germany, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 28: France, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 29: France, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 30: Eastern Europe, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 31: Eastern Europe, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 32: Russia, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 33: Russia, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 34: North America, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 35: North America, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 36: USA, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 37: USA, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 38: South America, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 39: South America, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 40: Brazil, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 41: Brazil, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 42: Middle East, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 43: Middle East, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 44: Africa, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 45: Africa, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 46: Abbott Laboratories Financial Performance
  • Table 47: Amgen Inc Financial Performance
  • Table 48: Baxter International Inc Financial Performance
  • Table 49: Eli Lilly and Company Financial Performance
  • Table 50: F. Hoffmann-La Roche Ltd Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Figure 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Figure 3: Global Therapeutic Proteins Market, Segmentation  By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 4: Global Therapeutic Proteins Market, Segmentation  By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 5: Global Therapeutic Proteins Market, Segmentation  By Function, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 6: Global Therapeutic Proteins Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global Therapeutic Proteins Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: China, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: China, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 12: India, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 13: India, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 14: Japan, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 15: Japan, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 16: Australia, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 17: Australia, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 18: Indonesia, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 19: Indonesia, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 20: South Korea, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 21: South Korea, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 22: Western Europe, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 23: Western Europe, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 24: UK, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 25: UK, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 26: Germany, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 27: Germany, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 28: France, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 29: France, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 30: Eastern Europe, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 31: Eastern Europe, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 32: Russia, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 33: Russia, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 34: North America, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 35: North America, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 36: USA, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 37: USA, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 38: South America, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 39: South America, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 40: Brazil, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 41: Brazil, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 42: Middle East, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 43: Middle East, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 44: Africa, Therapeutic Proteins Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 45: Africa, Therapeutic Proteins Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 46: Abbott Laboratories Financial Performance
  • Figure 47: Amgen Inc Financial Performance
  • Figure 48: Baxter International Inc Financial Performance
  • Figure 49: Eli Lilly and Company Financial Performance
  • Figure 50: F. Hoffmann-La Roche Ltd Financial Performance
Global Cancer Monoclonal Antibodies Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Clinical Nutrition Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cervical Cancer Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Central Nervous System Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Checkpoint Inhibitors Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cell Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cell Culture Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cell And Gene Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Dry Eye Medication Market - By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
COVID19 Vaccine & Therapeutics Clinical Trial Analysis 2020
View Report
COVID19 Vaccine And Therapeutics Pipeline Analysis 2020
View Report
Pharmaceutical Drugs Market - By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Musculoskeletal Drugs Market Global Briefing 2018
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)